Yazbeck & Co.

Our mission is create a high return on investment for our portfolio companies.

About Us

Yazbeck & Co, formerly Yazbeck Investments, is a full-service investment consulting firm providing international advisory services to small to medium size companies around the world. We focus on capital raises up to $10M and have raised over $100M in funding for various startups in our portfolio. We also specialize in mergers and acquisitions, valuations, restructuring, and divestures. Finally, we invest via our own fund.

Primary Industries of Investment

  • Pharmaceutical/Healthcare
  • Real Estate
  • Agriculture
  • Advanced Technologies
  • Clean Energy
  • Entertainment
  • Humanitarian Initiatives

Our Leadership Team

Daniel Yazbeck, M.Sc.
Founder and CEO

Daniel Yazbeck is a former Pfizer scientist, Panasonic new product, market and business developer, and a seasoned CEO with a track record of successfully launching products from concept to implementation. As a strategic marketer of the companies he backs, Mr. Yazbeck has been featured in BloombergCNNVICE NewsFast CompanyABCNBCPBSCNET, amongst others. Yazbeck Investments was founded in 2008 and focused on asset backed cashflow investments until 2013, when it started investing in the healthcare, advanced technologies and legal cannabis industries.

Jason Laba, LLB.,
Senior Managing Director

Jason Laba is a Senior Managing Director at Yazbeck & Co. With over ten years of investment experience, Mr. Laba has successfully advised on multiple transactions in Canada, the United States and internationally across a variety of industries. Prior to joining Yazbeck & Co., Mr. Laba worked for the Legislative Assembly of Ontario in Canada. Additionally, Mr. Laba was the Chief Executive Officer of Natural Stems, an early stage medical cannabis company.

Mr. Laba graduated with a Bachelor of Law degree from the University of Liverpool and received his National Committee of Accreditation certificate from the Federation of Law Societies of Canada.

Recent Transactions

Investments | In the News | Contact